GlassScriptPhysician profile
Marc A Norris
NPI 1851372668
$4,627.55
in general payments reported to CMS, 2019-2025
20 companies · $190 in 2025
The $190 reported for 2025 was less than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $691 · 2020: $125 · 2021: $141 · 2022: $2,166 · 2023: $592 · 2024: $722 · 2025: $190.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,504.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,504.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bolton Medical INC | $2,207.88 | 2019-2023 | Relay Thoracic Stent-Graft With Plus Delivery System |
| Silk Road Medical, INC. | $406.81 | 2022-2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Cook Medical LLC | $352.81 | 2020-2024 | Zenith |
| Bard Peripheral Vascular, INC. | $323.78 | 2019 | |
| Terumo Medical Corporation | $279.00 | 2019-2024 | R2p Misago, Metacross Otw |
| Shockwave Medical, INC | $200.17 | 2022-2025 | |
| Veryan Medical Incorporated | $145.75 | 2024 | Biomimics 3d Vascular Stent System |
| Boston Scientific Corporation | $114.60 | 2024 | Eluvia |
| Medtronic Vascular, INC. | $105.84 | 2019 | |
| Philips North America LLC | $97.01 | 2023-2024 | (Br5) Peripheral Ivus |
| Endologix LLC | $90.97 | 2023 | Alto Abdominal Stent Graft System |
| Medtronic, INC. | $69.09 | 2023 | Endurant Iis |
| Janssen Pharmaceuticals, INC | $58.07 | 2019-2021 | |
| Solventum Corporation | $37.57 | 2025 | Activ.A.C. |
| Smith+Nephew, INC. | $27.23 | 2023 | Grafix Pl, Stravix |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aroa Biosurgery Incorporated | $26.43 | 2024 | |
| Abbott Laboratories | $23.15 | 2022 | |
| Novo Nordisk INC | $22.59 | 2025 | Wegovy |
| Kerecis Limited | $21.97 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide, Kerecis Omega3 Surgiclose |
| Reflow Medical INC | $16.83 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marc Norris listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.